AbbVie
Patents, Design & Utilities

Last updated:

List of all AbbVie patents 265 in total

Status Patent
Application
Utility: PROLACTIN RECEPTOR BINDING PROTEINS AND USES THEREOF External link
Filling date: 12 Sep 2025 Issue date: 11 Mar 2021
Application
Utility: LEVODOPA AND CARBIDOPA INTESTINAL GEL AND METHODS OF USE External link
Filling date: 12 Sep 2025 Issue date: 4 Mar 2021
Application
Utility: ANTI-PRLR ANTIBODY-DRUG CONJUGATES (ADC) AND USES THEREOF External link
Filling date: 12 Sep 2025 Issue date: 4 Mar 2021
Application
Utility: NOVEL TRICYCLIC COMPOUNDS External link
Filling date: 12 Sep 2025 Issue date: 4 Mar 2021
Application
Utility: Bromodomain Inhibitors External link
Filling date: 12 Sep 2025 Issue date: 18 Feb 2021
Application
Utility: LEVODOPA AND CARBIDOPA INTESTINAL GEL AND METHODS OF USE External link
Filling date: 12 Sep 2025 Issue date: 18 Feb 2021
Grant
Utility: Methods and compositions for treating asthma using anti-IL-13 antibodies External link
Filling date: 12 Sep 2025 Issue date: 16 Feb 2021
Application
Utility: Single-Chain Trail-Receptor Agonist Proteins External link
Filling date: 12 Sep 2025 Issue date: 11 Feb 2021
Application
Utility: SYSTEMS AND METHODS FOR IDENTIFYING PROTEIN AGGREGATES IN BIOTHERAPEUTICS External link
Filling date: 12 Sep 2025 Issue date: 11 Feb 2021
Grant
Utility: Modulators of the integrated stress pathway External link
Filling date: 12 Sep 2025 Issue date: 9 Feb 2021
Application
Utility: Electronic Pill Dispenser and Related Methods of Use External link
Filling date: 12 Sep 2025 Issue date: 4 Feb 2021
Application
Utility: Solid Pharmaceutical Compositions for Treating HCV External link
Filling date: 12 Sep 2025 Issue date: 28 Jan 2021
Application
Utility: ECTONUCLEOTIDE PYROPHOSPHATE-PHOSPHODIESTERASE (ENPP) CONJUGATES AND USES THEREOF External link
Filling date: 12 Sep 2025 Issue date: 28 Jan 2021
Application
Utility: ORGANIC REACTIONS CARRIED OUT IN AQUEOUS SOLUTION IN THE PRESENCE OF A HYDROXYALKYL(ALKYL)CELLULOSE OR AN ALKYLCELLULOSE External link
Filling date: 12 Sep 2025 Issue date: 21 Jan 2021
Application
Utility: GLUCOCORTICOID RECEPTOR AGONIST AND IMMUNOCONJUGATES THEREOF External link
Filling date: 12 Sep 2025 Issue date: 21 Jan 2021
Application
Utility: SELECTIVE REDUCTION OF ANTIBODIES External link
Filling date: 12 Sep 2025 Issue date: 21 Jan 2021
Application
Utility: PROTEIN TYROSINE PHOSPHATASE INHIBITORS AND METHODS OF USE THEREOF External link
Filling date: 12 Sep 2025 Issue date: 14 Jan 2021
Application
Utility: Therapeutic DLL4 Binding Proteins External link
Filling date: 12 Sep 2025 Issue date: 14 Jan 2021
Grant
Utility: Methods of treating heavy menstrual bleeding External link
Filling date: 12 Sep 2025 Issue date: 5 Jan 2021
Application
Utility: ANTI-EGFR ANTIBODIES AND ANTIBODY DRUG CONJUGATES External link
Filling date: 12 Sep 2025 Issue date: 31 Dec 2020
Grant
Utility: High purity oritavancin and method of producing same External link
Filling date: 12 Sep 2025 Issue date: 15 Dec 2020
Grant
Utility: Modulators of the integrated stress pathway External link
Filling date: 12 Sep 2025 Issue date: 15 Dec 2020
Application
Utility: Stable Dual Variable Domain Immunoglobulin Protein Formulations External link
Filling date: 12 Sep 2025 Issue date: 10 Dec 2020
Application
Utility: PROCESSES FOR THE PREPARATION OF (3S,4R)-3-ETHYL-4-(3H-IMIDAZO[1,2-a]PYRROLO[2,3-e]-PYRAZIN-8-YL)-N-(2,2,2- -TRIFLUOROETHYL)PYRROLIDINE-1-CARBOXAMIDE AND SOLID STATE FORMS THEREOF External link
Filling date: 12 Sep 2025 Issue date: 10 Dec 2020
Grant
Utility: Automatic injection device External link
Filling date: 12 Sep 2025 Issue date: 8 Dec 2020
Grant
Utility: Protein tyrosine phosphatase inhibitors and methods of use thereof External link
Filling date: 12 Sep 2025 Issue date: 1 Dec 2020
Application
Utility: Methods of Treating Glioblastoma External link
Filling date: 12 Sep 2025 Issue date: 26 Nov 2020
Application
Utility: Methods for Treating HCV External link
Filling date: 12 Sep 2025 Issue date: 26 Nov 2020
Application
Utility: PROCESSES FOR THE PREPARATION OF (3S,4R)-3-ETHYL-4-(3H-IMIDAZO[1,2-a]PYRROLO[2,3-e]-PYRAZIN-8-YL)-N-(2,2,2- -TRIFLUOROETHYL)PYRROLIDINE-1-CARBOXAMIDE AND SOLID STATE FORMS THEREOF External link
Filling date: 12 Sep 2025 Issue date: 19 Nov 2020
Application
Utility: SALTS AND CRYSTALLINE FORMS OF AN APOPTOSIS-INDUCING AGENT External link
Filling date: 12 Sep 2025 Issue date: 19 Nov 2020
Application
Utility: MODULATORS OF THE INTEGRATED STRESS PATHWAY External link
Filling date: 12 Sep 2025 Issue date: 19 Nov 2020
Application
Utility: MODULATORS OF THE INTEGRATED STRESS PATHWAY External link
Filling date: 12 Sep 2025 Issue date: 19 Nov 2020
Grant
Utility: Organic reactions carried out in aqueous solution in the presence of a hydroxyalkyl(alkyl)cellulose or an alkylcellulose External link
Filling date: 12 Sep 2025 Issue date: 17 Nov 2020
Grant
Utility: Modulators of the integrated stress pathway External link
Filling date: 12 Sep 2025 Issue date: 17 Nov 2020
Grant
Utility: Fused heterocyclic derivatives as S1P modulators External link
Filling date: 12 Sep 2025 Issue date: 10 Nov 2020
Application
Utility: MEDICATION PACKAGING AND DISPENSING SYSTEM External link
Filling date: 12 Sep 2025 Issue date: 5 Nov 2020
Application
Utility: MODULATORS OF THE INTEGRATED STRESS PATHWAY External link
Filling date: 12 Sep 2025 Issue date: 5 Nov 2020
Application
Utility: APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES External link
Filling date: 12 Sep 2025 Issue date: 5 Nov 2020
Application
Utility: METHODS FOR TREATING SPINAL CORD INJURY AND PAIN External link
Filling date: 12 Sep 2025 Issue date: 5 Nov 2020
Application
Utility: MODULATORS OF THE INTEGRATED STRESS PATHWAY External link
Filling date: 12 Sep 2025 Issue date: 5 Nov 2020
Application
Utility: MODULATORS OF THE INTEGRATED STRESS PATHWAY External link
Filling date: 12 Sep 2025 Issue date: 5 Nov 2020
Grant
Utility: Composition and method for the diagnosis and treatment of iron-related disorders External link
Filling date: 12 Sep 2025 Issue date: 3 Nov 2020
Application
Utility: GLUCOCORTICOID RECEPTOR AGONIST AND IMMUNOCONJUGATES THEREOF External link
Filling date: 12 Sep 2025 Issue date: 29 Oct 2020
Application
Utility: ANTI-B7-H3 ANTIBODIES AND ANTIBODY DRUG CONJUGATES External link
Filling date: 12 Sep 2025 Issue date: 29 Oct 2020
Application
Utility: APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES External link
Filling date: 12 Sep 2025 Issue date: 22 Oct 2020
Application
Utility: Methods for Treating HCV External link
Filling date: 12 Sep 2025 Issue date: 22 Oct 2020
Grant
Utility: Spiro-cyclic amine derivatives as S1P modulators External link
Filling date: 12 Sep 2025 Issue date: 20 Oct 2020
Grant
Utility: Systems and methods for tubing delivery External link
Filling date: 12 Sep 2025 Issue date: 20 Oct 2020
Application
Utility: Macrocyclic MCL-1 Inhibitors and Methods of Use External link
Filling date: 12 Sep 2025 Issue date: 15 Oct 2020
Application
Utility: PROCESS FOR THE PREPARATION OF (S)-2-AMINO-NON-8-ENOIC ACID External link
Filling date: 12 Sep 2025 Issue date: 15 Oct 2020

Showing 100 to 150 of 265 patents.